TWiV 897: COVID-19 clinical update #113 with Dr. Daniel Griffin

May 7, 2022

In COVID-19 clinical update #113, Dr. Griffin discusses tocilizumab use in hospitalized Patients, IL-6 inhibitors and mortality, Baricitinib in hospitalized patients, post-infection neurological sequelae, comparative effectiveness of Pfizer and Moderna vaccines, phase 2/3 study of Paxlovid, infection relapse following Paxlovid, pre-hospital administration of Remdesivir, and hospitalization with different variants.

Click arrow to play
Download TWiV 897 (29 MB .mp3, 48 min)
Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to

Leave a Reply

Your email address will not be published. Required fields are marked *

2 comments on “TWiV 897: COVID-19 clinical update #113 with Dr. Daniel Griffin

  1. N. Adams May 11, 2022

    Thanks. I particularly like the morality aspect in: ‘Different Variants Hospitalization and Morality (Res Square)’